BMO Capital's Kelly Bania reiterates Market Perform for Target but lowers the price target from $170 to $155. Despite 1Q results meeting expectations, concerns arise over continued gross margin upside, share losses in food and consumables, and competition from Amazon and Walmart.
Unlock the latest on Royalty Pharma plc & Cytokinetics Inc.'s strategic funding collaboration for aficamten's commercialization and cardiovascular pipeline expansion.
Upgraded to Outperform with $270 price target by RBC analyst due to expected improvement in operating ratio and EPS growth, making NSC an attractive investment opportunity.
GoodRx has been upgraded by RBC Capital Markets due to the growth potential from the Integrated Savings Program, direct contracting initiatives, and manufacturing solutions expansion.
Several analysts have updated coverage on E.l.f. Beauty, Inc. (NYSE:ELF) on Thursday after the company reported better-than-expected financial results for the fourth quarter. Piper Sandler named the stock as a "top pick" and highlighted the company's international growth opportunities and continued strength in the U.S. market after E.l.f. Beauty reported quarterly revenue growth of 71% year-over-year and $321.14 million in sales.
Lululemon Athletica Inc (NASDAQ:LULU) shares are trading higher Thursday. The stock appears to be bouncing back slightly after falling more than 7% on Wednesday after the company announced an updated operational structure following the resignation of its chief product officer.